Flow cytometric analysis of micronuclei in peripheral blood reticulocytes: II. An efficient method of monitoring chromosomal damage in the rat.

We have evaluated a flow cytometric method that allows assessment of micronucleated reticulocytes (MN-RETs) in microliter quantities of peripheral blood and compared results using this assay with those of established microscopic methods of scoring bone marrow and peripheral blood from rats treated with well-characterized genotoxic agents. Young reticulocytes (RETs) are labeled with FITC-anti-CD71 (transferrin receptor) and micronuclei with propidium iodide (with RNase treatment). Red blood cells parasitized with Plasmodia serve as a calibration standard for DNA content. Microscopic scoring used acridine orange (AO) staining of methanol-fixed slides or supravital AO staining. The effect of the rat spleen on the parameters evaluated was determined by comparing age- and sex-matched normal and splenectomized rats treated with cyclophosphamide, cis-platin, or vinblastine under treatment conditions that established a steady-state frequency of MN-RETs in the bone marrow and peripheral blood compartments. The data demonstrate the sensitivity and reproducibility of the flow cytometric assay in the Sprague-Dawley rat, and comparative studies using identical blinded samples at multiple laboratories show that inter- and intra-laboratory reproducibility is much higher with the flow method than with the microscopic methods currently employed for regulatory studies. A significant effect of splenic selection against genotoxicant-induced MN-RETs was observed with each of the three scoring methodologies, despite the fact that the flow and supravital AO techniques restrict analysis to the youngest fraction of RETs. The high precision of flow-based measurements also demonstrated a slight but statistically significant level of selection against spontaneously arising MN-RET. Despite these spleen effects, assay sensitivity for blood-based analyses was maintained by the flow method as it was shown to have superior counting statistics, lower variability, and higher sensitivity than manual scoring. The data suggest that flow cytometric assessment of micronucleus induction can be integrated into routine toxicity testing, eliminating the need for a separate bioassay.

[1]  S. Dertinger,et al.  Analysis of micronucleated cells by flow cytometry. 1. Achieving high resolution with a malaria model. , 1993, Mutation research.

[2]  M. Bergqvist,et al.  Human cytogenetic biomonitoring using flow‐cytometric analysis of micronuclei in transferrin‐positive immature peripheral blood reticulocytes , 2000, Environmental and molecular mutagenesis.

[3]  Stephen D Dertinger,et al.  In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test. , 2007, Mutation research.

[4]  S. Dertinger,et al.  Enumeration of micronucleated reticulocytes in rat peripheral blood: a flow cytometric study. , 2000, Mutation research.

[5]  S. Dertinger,et al.  Enumeration of micronucleated CD71-positive human reticulocytes with a single-laser flow cytometer. , 2002, Mutation research.

[6]  W. Schmid.  The Micronucleus Test for Cytogenetic Analysis , 1976 .

[7]  J. T. Macgregor,et al.  In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring , 2000, Environmental and Molecular Mutagenesis.

[8]  A. Wakata,et al.  Evaluation of the rodent micronucleus assay by a 28‐day treatment protocol: Summary of the 13th Collaborative Study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Environmental Mutagen Society of Japan (JEMS)–Mammalian Mutagenicity Study Group (MMS) , 2001, Environmental and molecular mutagenesis.

[9]  D. Plumb.  Veterinary Drug Handbook , 1999 .

[10]  J. T. Macgregor,et al.  Association of marginal folate depletion with increased human chromosomal damage in vivo: demonstration by analysis of micronucleated erythrocytes. , 1988, Journal of the National Cancer Institute.

[11]  J. T. Macgregor,et al.  The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene-Tox Program. , 1983, Mutation research.

[12]  K. Witt,et al.  Elevated frequencies of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother‐to‐child transmission of HIV , 2007, Environmental and molecular mutagenesis.

[13]  M D Shelby,et al.  Micronucleated erythrocyte frequency in peripheral blood of B6C3F1 mice from short‐term, prechronic, and chronic studies of the NTP carcinogenesis bioassay program , 2000, Environmental and molecular mutagenesis.

[14]  R. Schlegel,et al.  Assessment of cytogenetic damage by quantitation of micronuclei in human peripheral blood erythrocytes. , 1986, Cancer research.

[15]  M. Fenech,et al.  Flow cytometric enumeration of micronucleated reticulocytes: High transferability among 14 laboratories , 2001, Environmental and molecular mutagenesis.

[16]  P. Harbach,et al.  Interlaboratory validation of a CD71‐based flow cytometric method (Microflow®) for the scoring of micronucleated reticulocytes in mouse peripheral blood , 2005, Environmental and molecular mutagenesis.

[17]  Makoto Hayashi,et al.  Evaluation of the rat micronucleus test with bone marrow and peripheral blood: Summary of the 9th collaborative study by CSGMT/JEMS·MMS , 1998, Environmental and molecular mutagenesis.

[18]  T. Sofuni,et al.  The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. , 1990, Mutation research.

[19]  S. Dertinger,et al.  Malaria-infected erythrocytes serve as biological standards to ensure reliable and consistent scoring of micronucleated erythrocytes by flow cytometry. , 2000, Mutation research.

[20]  Yuhchyau Chen,et al.  Automated human blood micronucleated reticulocyte measurements for rapid assessment of chromosomal damage. , 2007, Mutation research.

[21]  J. T. Macgregor,et al.  Flow cytometric analysis of micronuclei in peripheral blood reticulocytes: I. Intra- and interlaboratory comparison with microscopic scoring. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  R. Schlegel,et al.  Micronuclei in circulating erythrocytes: a rapid screen for chromosomal damage during routine toxicity testing in mice. , 1983, Developments in toxicology and environmental science.

[23]  J. T. Macgregor,et al.  Integration of cytogenetic assays with toxicology studies , 1995, Environmental and molecular mutagenesis.

[24]  M A Kastenbaum,et al.  Tables for determining the statistical significance of mutation frequencies. , 1970, Mutation research.

[25]  B. Ames,et al.  A simple assay for frequency of chromosome breaks and loss (micronuclei) by flow cytometry of human reticulocytes , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  Division on Earth.  Guide for the Care and Use of Laboratory Animals , 1996 .

[27]  J. T. Macgregor,et al.  Clastogen-induced micronuclei in peripheral blood erythrocytes: the basis of an improved micronucleus test. , 1980, Environmental mutagenesis.

[28]  M. Shelby,et al.  Micronuclei as an index of cytogenetic damage: Past, present, and future , 1991, Environmental and molecular mutagenesis.

[29]  M. Shelby,et al.  The in vivo erythrocyte micronucleus test: measurement at steady state increases assay efficiency and permits integration with toxicity studies. , 1990, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[30]  L. Abramsson-Zetterberg,et al.  The micronucleus test in rat erythrocytes from bone marrow, spleen and peripheral blood: the response to low doses of ionizing radiation, cyclophosphamide and vincristine determined by flow cytometry. , 1999, Mutation research.

[31]  T. Sofuni,et al.  An application of Acridine Orange fluorescent staining to the micronucleus test. , 1983, Mutation research.

[32]  C. Reiners,et al.  Evaluation of the reticulocyte micronucleus assay in patients treated with radioiodine for thyroid cancer. , 2005, Mutation research.

[33]  R R Tice,et al.  In vivo rodent erythrocyte micronucleus assay. , 1994, Mutation research.

[34]  B. Margolin,et al.  Guidelines for the conduct of micronucleus assays in mammalian bone marrow erythrocytes. , 1987, Mutation research.

[35]  S. Dertinger,et al.  Simple and reliable enumeration of micronucleated reticulocytes with a single-laser flow cytometer. , 1996, Mutation research.

[36]  A. Heidland,et al.  Pilot study for comparison of reticulocyte-micronulei with lymphocyte-micronuclei in human biomonitoring. , 2005, Toxicology letters.

[37]  R. Schlegel,et al.  The persistence of micronucleated erythrocytes in the peripheral circulation of normal and splenectomized Fischer 344 rats: implications for cytogenetic screening. , 1984, Mutation research.

[38]  Yuhchyau Chen,et al.  Micronucleated CD71-positive reticulocytes: a blood-based endpoint of cytogenetic damage in humans. , 2003, Mutation research.

[39]  Stephen D Dertinger,et al.  Comparative scoring of micronucleated reticulocytes in rat peripheral blood by flow cytometry and microscopy. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[40]  T. Sofuni,et al.  The micronucleus assay using peripheral blood reticulocytes from mitomycin C- and cyclophosphamide-treated rats. , 1992, Mutation research.

[41]  K. Camphausen,et al.  Three‐color labeling method for flow cytometric measurement of cytogenetic damage in rodent and human blood , 2004, Environmental and molecular mutagenesis.